112 related articles for article (PubMed ID: 16316729)
1. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. I: Formulation and in vitro characterization.
Lu B; Xiong SB; Yang H; Yin XD; Zhao RB
Int J Pharm; 2006 Jan; 307(2):168-74. PubMed ID: 16316729
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: Tissue distribution and pharmacodynamics.
Lu B; Xiong SB; Yang H; Yin XD; Zhao RB
Int J Pharm; 2006 Jan; 307(2):175-81. PubMed ID: 16314056
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
Lu B; Xiong SB; Yang H; Yin XD; Chao RB
Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
[TBL] [Abstract][Full Text] [Related]
4. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan.
Chen H; Yang W; Chen H; Liu L; Gao F; Yang X; Jiang Q; Zhang Q; Wang Y
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):212-8. PubMed ID: 19545985
[TBL] [Abstract][Full Text] [Related]
5. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
[TBL] [Abstract][Full Text] [Related]
6. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin.
Zheng CH; Liang WQ; Li F; Zhang YP; Fang WJ
Pharmazie; 2005 Jun; 60(6):434-8. PubMed ID: 15997832
[TBL] [Abstract][Full Text] [Related]
7. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery.
Li C; Xing L; Che S
Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
[TBL] [Abstract][Full Text] [Related]
9. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy.
Deng Z; Zhen Z; Hu X; Wu S; Xu Z; Chu PK
Biomaterials; 2011 Jul; 32(21):4976-86. PubMed ID: 21486679
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of a model protein into chitosan-bile salt microparticles.
Lameiro MH; Lopes A; Martins LO; Alves PM; Melo E
Int J Pharm; 2006 Apr; 312(1-2):119-30. PubMed ID: 16480840
[TBL] [Abstract][Full Text] [Related]
11. Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
Cui J; Li C; Wang L; Wang C; Yang H; Li Y; Zhang L; Zhang L; Guo W; Liang M
Int J Pharm; 2009 Feb; 368(1-2):24-30. PubMed ID: 18973800
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
[TBL] [Abstract][Full Text] [Related]
14. Reduced dose-limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes.
Chang RS; Kim J; Lee HY; Han SE; Na J; Kim K; Kwon IC; Kim YB; Oh YK
Nanomedicine; 2010 Dec; 6(6):769-76. PubMed ID: 20570638
[TBL] [Abstract][Full Text] [Related]
15. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
[TBL] [Abstract][Full Text] [Related]
16. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
17. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
18. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor.
Xu Y; Asghar S; Gao S; Chen Z; Huang L; Yin L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7337-7350. PubMed ID: 29066886
[TBL] [Abstract][Full Text] [Related]
20. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
Wang LY; Gu YH; Su ZG; Ma GH
Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
